ARTICLE | Company News
Affymax, Fresenius Medical Care AG & Co. KGaA, Takeda deal
February 18, 2013 8:00 AM UTC
Last March, FDA approved the once-monthly erythropoiesis-stimulating agent (ESA) to treat anemia in chronic kidney disease (CKD) patients who are on dialysis. The product uses pegylation technology fr...